According to IMARC Group, the global PET-CT Scanner Device Market size reached USD 2.4 Billion in 2025 and is projected to reach USD 3.3 Billion by 2034, exhibiting a CAGR of 3.33% during 2026–2034. This steady PET-CT Scanner Device Market growth reflects the rising prevalence of cancer and chronic diseases, rapid technological advancements in imaging equipment, and the growing demand for non-invasive, precise diagnostic solutions across global healthcare systems.

PET-CT Scanner Device Industry Overview

The PET-CT Scanner Device Market sits at the crossroads of nuclear medicine, radiology, and advanced computing. PET-CT scanners combine two powerful imaging modalities into a single, seamless diagnostic session: PET scans reveal real-time metabolic and biochemical activity, while CT scans provide high-resolution anatomical mapping. Together, they give clinicians a comprehensive view of both the structure and function of tissues and organs — a capability that single-modality scanners simply cannot match.

PET-CT scanners are categorized by several key attributes:

• Type: Stationary Scanners and Portable/Mobile Scanners
• Slice Count: Low Slice (<64 Slices), Medium Slice (64 Slices), and High Slice (>64 Slices)
• Isotope & Detector Type: Fluorodeoxyglucose (FDG), 62Cu ATSM, 18F Sodium Fluoride, FMISO, Gallium, Thallium, and others
• Service Provider: Hospitals, Diagnostic Centers, and Research Institutes
• Application: Oncology, Neurology, Cardiology, and other specialties

These devices are widely deployed across hospitals, specialty diagnostic centers, and academic research institutions seeking to push the boundaries of disease detection, treatment monitoring, and clinical research.

Global Market Overview & PET-CT Scanner Device Market Statistics

Below are the key PET-CT Scanner Device Market statistics drawn from IMARC Group's comprehensive market analysis:

Request for a Sample Report for Detailed Market Insights Evaluation: https://www.imarcgroup.com/pet-ct-scanner-device-market/requestsample

Key Market Drivers & PET-CT Scanner Device Market Trends in 2026

Several powerful forces are shaping PET-CT Scanner Device Market trends and fueling steady growth expectations across global healthcare markets:

1. Rising Prevalence of Cancer and Chronic Diseases

The growing global cancer burden is one of the most significant drivers of PET-CT Scanner Device Market growth. PET-CT scanners are indispensable in cancer diagnosis, staging, and treatment monitoring. Their ability to detect metabolic activity within tumors enables early-stage detection, which dramatically improves treatment efficacy and patient survival rates. As lifestyle-related risk factors — including sedentary behavior, poor nutrition, and environmental pollutants — continue to drive cancer incidence worldwide, the demand for advanced PET-CT diagnostic equipment is intensifying.

2. Continuous Technological Advancements

Ongoing innovations in scanner hardware, detector technology, and AI-powered image reconstruction algorithms are transforming PET-CT capabilities. Modern systems deliver higher spatial resolution, shorter scan times, and lower radiation doses — addressing both clinical and patient safety imperatives. The integration of artificial intelligence (AI) into PET-CT workflows is further augmenting diagnostic accuracy and streamlining radiologist workflows. These technological advancements are a core element of PET-CT Scanner Device Market trends, as healthcare providers prioritize the latest equipment for competitive differentiation.

3. Growing Geriatric Population

The world's population is aging rapidly, with the elderly being disproportionately susceptible to cancer, cardiovascular disorders, and neurological conditions such as Alzheimer's disease. This demographic shift is expanding the pool of patients requiring advanced diagnostic imaging, driving sustained demand for PET-CT scanners in hospitals, diagnostic centers, and research institutes. The growing geriatric population is thus a structural tailwind for PET-CT scanner device market share across both developed and emerging economies.

4. Expanding Healthcare Infrastructure in Emerging Markets

Rapid expansion of hospital networks, diagnostic centers, and specialty clinics across Asia Pacific, the Middle East, and Latin America is creating substantial new demand for PET-CT equipment. Governments and private sector investors are channeling significant capital into healthcare modernization programs, creating a fertile environment for PET-CT market penetration in regions previously underserved by advanced nuclear medicine capabilities.

5. Increasing Applications Beyond Oncology

While oncology remains the dominant application segment, PET-CT is increasingly adopted in neurology (for conditions like dementia, epilepsy, and Parkinson's disease) and cardiology (for coronary artery disease assessment and cardiac viability testing). This broadening of clinical applications is materially expanding the addressable PET-CT Scanner Device Market size beyond cancer-related diagnostics.

6. Rising Adoption of Point-of-Care and Portable Scanners

The development of compact and portable PET-CT scanners is enabling point-of-care (PoC) imaging, allowing advanced diagnostics to reach patients in settings where large stationary equipment is impractical. This innovation is anticipated to be among the most influential PET-CT Scanner Device Market trends over the coming years, particularly in rural healthcare settings and mobile diagnostic units.

Key Market Segmentation

By Type

• Stationary Scanners – Largest Segment: Stationary PET-CT scanners command the largest PET-CT Scanner Device Market share due to their superior imaging performance, high throughput capacity, and established presence in hospital radiology departments and dedicated diagnostic centers. These systems deliver the highest imaging quality and are optimized for high-volume clinical environments.
• Portable/Mobile Scanners: The portable scanner segment is one of the fastest-growing areas of the market, driven by demand for flexible, point-of-care imaging solutions in remote clinics, mobile diagnostic units, and resource-limited settings.

By Slice Count

• Low Slice Scanner (<64 Slices): Used in budget-sensitive environments and smaller diagnostic facilities.
• Medium Slice Scanner (64 Slices): A widely adopted configuration offering a balance of cost and diagnostic capability.
• High Slice Scanner (>64 Slices) – Largest Segment: High slice scanners deliver the most detailed anatomical imaging and are preferred in complex oncology and cardiology applications at tertiary hospitals and research centers.

By Service Provider

• Hospitals – Largest Segment: Hospitals account for the largest end-use PET-CT Scanner Device Market share. Their high patient volumes, comprehensive oncology, neurology, and cardiology departments, and access to radiopharmaceuticals position them as the primary buyers of PET-CT scanner technology. Outsourcing partners help hospitals maximize scanner utilization, reduce operational costs, and maintain regulatory compliance.
• Diagnostic Centers: Standalone and chain diagnostic centers represent a rapidly growing channel for PET-CT adoption, particularly in urban markets where outpatient imaging demand is high.
• Research Institutes: Academic and government research organizations utilize PET-CT scanners for clinical trials, neuroscience research, and drug development applications.

By Application

• Oncology – Largest Segment: Oncology drives the majority of PET-CT scans globally. PET-CT is the gold standard for cancer staging, restaging, therapy response monitoring, and recurrence detection.
• Neurology: Growing adoption in Alzheimer's disease, epilepsy, and movement disorder evaluation.
• Cardiology: Used for myocardial perfusion imaging and viability assessment.
• Others: Includes infection and inflammation imaging, pediatric diagnostics, and emerging research applications.

Regional Market Analysis

Connect for Detailed Segmentation Analysis – Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=1946&flag=C

Leading Players in the PET-CT Scanner Device Industry

The global PET-CT Scanner Device Market features a concentrated competitive landscape dominated by established medical imaging giants alongside innovative niche players. The competitive analysis in the IMARC Group report covers market structure, player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Key companies covered include:

• Bruker Corporation
• Canon Medical Systems Corporation (Canon Inc.)
• CMR Naviscan
• Fujifilm Holdings Corporation
• General Electric Company (GE Healthcare)
• Koninklijke Philips N.V.
• MinFound Medical Systems Co. Ltd.
• Neusoft Medical Systems Co. Ltd.
• Positron Corporation
• Shimadzu Corporation
• Siemens Healthineers AG (Siemens AG)
• United Imaging Healthcare Co. Ltd.

About Us

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Healthcare, Technology, Chemicals, Energy, Food & Beverages, and more.

Contact Us

IMARC Group

United States: +1-201-971-6302

India: +91-120-433-0800

United Kingdom: +44-753-714-6104